US BANCORP \DE\ - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,267,028
-22.6%
47,154
+2.7%
0.00%
-33.3%
Q2 2023$1,638,006
+50.9%
45,934
+7.5%
0.00%
+50.0%
Q1 2023$1,085,672
+49.0%
42,743
+138.0%
0.00%
+100.0%
Q4 2022$728,539
-1.5%
17,962
-19.7%
0.00%
-50.0%
Q3 2022$740,000
+30.7%
22,362
+39.2%
0.00%
+100.0%
Q2 2022$566,000
-29.3%
16,070
-7.7%
0.00%0.0%
Q1 2022$801,000
-26.0%
17,418
+6.5%
0.00%
-50.0%
Q4 2021$1,082,000
+17.4%
16,349
+10.8%
0.00%0.0%
Q3 2021$922,000
-18.3%
14,759
+8.4%
0.00%0.0%
Q2 2021$1,128,000
+34.9%
13,619
+8.1%
0.00%0.0%
Q1 2021$836,000
+141.6%
12,595
+179.4%
0.00%
+100.0%
Q4 2020$346,000
+81.2%
4,508
+1.2%
0.00%
Q3 2020$191,000
-5.0%
4,454
-4.4%
0.00%
-100.0%
Q2 2020$201,000
+44.6%
4,661
-3.7%
0.00%
Q1 2020$139,000
-57.1%
4,841
-5.2%
0.00%
-100.0%
Q4 2019$324,000
+138.2%
5,108
+5.8%
0.00%
Q3 2019$136,000
+10.6%
4,830
+4.8%
0.00%
Q2 2019$123,000
+50.0%
4,608
+2.7%
0.00%
Q1 2019$82,000
+39.0%
4,486
-5.6%
0.00%
Q4 2018$59,000
+742.9%
4,751
+375.1%
0.00%
Q3 2016$7,000
+40.0%
1,0000.0%0.00%
Q2 2016$5,0001,0000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders